Danaher Corp
NYSE: DHR
$245.39
-$0.71 (-0.3%)
Closing Price on November 8, 2024
DHR Articles
The week of September 28 saw many analyst upgrades and positive calls in blue-chip stocks. Here are six that received very favorable analyst coverage with above-consensus upside projections.
Published:
Last Updated:
The corporate spreads in U.S. corporate bonds are now low enough, on top of record-low interest rates, that companies would be foolish to ignore the opportunity to grab vast amounts of capital on the...
Published:
Last Updated:
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
Published:
Last Updated:
If there is one former Dow Jones industrial average leader that is in need of serious help, look no further than General Electric.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday included Caterpillar, CenturyLink, Danaher, Dillard's, Intel, Intelsat, Mattel, ONEOK, PG&E and Windstream.
Published:
Last Updated:
Investors and speculators just love a good merger and acquisition story. The story of General Electric selling its Life Sciences biotechnology instrument division to Danaher is one of those fairy...
Published:
Last Updated:
Monday was a positive day for the broad U.S. markets. As this week goes on we are looking forward to some more major retailers posting their quarterly results. Crude oil backed off in the session....
Published:
Last Updated:
Medical device maker Danaher has agreed to acquire GE's biopharma business for $21.4 billion in cash. The transaction is expected to be completed by the end of this year.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators...
Published:
Last Updated:
While the health care sector as a whole has had its ups and downs, there is no question that mergers and acquisitions can spike interest in the companies fast. Many on Wall Street feel that is...
Published:
Last Updated:
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no...
Published:
Last Updated:
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Amgen, Caterpillar, Dollar General, Duke Energy, General Electric, Honeywell, 3M, Netflix and Sprint.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Check Point Software, Coca-Cola, Kraft Heinz, PepsiCo and UnitedHealth.
Published:
Last Updated:
Analysts at Merrill Lynch have made a big move by adding a top consumer goods stock and a life sciences company to the firm's well-respected US 1 list of stocks, while removing a utility stock.
Published:
Last Updated: